Clinical Trial Update: Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women [Phase 2]

View source ↗

Summary

Phase 2 study of gabapentin extended-release for vasomotor symptoms in postmenopausal women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause-related Vasomotor Symptoms

Drugs mentioned

• Gabapentin Extended Release (G-ER) (gabapentin extended-release)

Snippet

Sponsor: Depomed | Conditions: Hot Flashes | Phase 2 | Status: COMPLETED